BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23824394)

  • 1. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.
    Miller BJ; Cram P; Lynch CF; Buckwalter JA
    J Bone Joint Surg Am; 2013 Jul; 95(13):e89. PubMed ID: 23824394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database.
    Duchman KR; Gao Y; Miller BJ
    Cancer Epidemiol; 2015 Aug; 39(4):593-9. PubMed ID: 26002013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for detectable metastatic disease at presentation in Ewing sarcoma - An analysis of the SEER registry.
    Ramkumar DB; Ramkumar N; Miller BJ; Henderson ER
    Cancer Epidemiol; 2018 Dec; 57():134-139. PubMed ID: 30412903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study.
    Xie L; Huang W; Wang H; Zheng C; Jiang J
    J Orthop Surg Res; 2020 Jan; 15(1):32. PubMed ID: 31996232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse impact of regional lymph node involvement in osteosarcoma.
    Thampi S; Matthay KK; Goldsby R; DuBois SG
    Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
    Wan L; Tu C; Li S; Li Z
    Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rural patients are at risk for increased stage at presentation and diminished overall survival in osteosarcoma.
    Wendt R; Gao Y; Miller BJ
    Cancer Epidemiol; 2019 Aug; 61():119-123. PubMed ID: 31212223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
    Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
    Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database.
    Duchman KR; Gao Y; Miller BJ
    Cancer Epidemiol; 2015 Apr; 39(2):189-95. PubMed ID: 25595632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.
    Song K; Song J; Lin K; Chen F; Ma X; Jiang J; Li F
    Int Orthop; 2019 Aug; 43(8):1983-1991. PubMed ID: 31127366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database.
    Pan Y; Chen D; Hu T; Lv G; Dai Z
    Cancer Control; 2019; 26(1):1073274819888893. PubMed ID: 31773978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteosarcoma of the Pelvis: Clinical Presentation and Overall Survival.
    Brown JM; Matichak D; Rakoczy K; Groundland J
    Sarcoma; 2021; 2021():8027314. PubMed ID: 34912177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
    Schneiderman BA; Kliethermes SA; Nystrom LM
    Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base.
    Miller BJ; Gao Y; Duchman KR
    Cancer Epidemiol; 2017 Aug; 49():112-117. PubMed ID: 28601784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
    Ilcisin LA; Ma C; Janeway KA; DuBois SG; Shulman DS
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28834. PubMed ID: 33258278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Metastasis at Initial Diagnosis With Ewing Sarcoma.
    Ye C; Dai M; Zhang B
    Front Oncol; 2019; 9():1043. PubMed ID: 31681581
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-based study.
    Huang X; Zhao J; Bai J; Shen H; Zhang B; Deng L; Sun C; Liu Y; Zhang J; Zheng J
    J Bone Oncol; 2019 Jun; 16():100230. PubMed ID: 30923668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing's sarcoma.
    Miller BJ; Lynch CF; Buckwalter JA
    Clin Orthop Relat Res; 2013 Nov; 471(11):3398-404. PubMed ID: 23821136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of extent of local tumor invasion and survival in patients with malignant primary osseous spinal neoplasms from the surveillance, epidemiology, and end results (SEER) database.
    Mukherjee D; Chaichana KL; Adogwa O; Gokaslan Z; Aaronson O; Cheng JS; McGirt MJ
    World Neurosurg; 2011 Dec; 76(6):580-5. PubMed ID: 22251507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.